RecruitingNCT06494436

Microvention AnEurysm & STroke Real-life Data cOllection

Microvention Aneurysm & Stroke Real-life Data Collection

Sponsor

Microvention-Terumo, Inc.

Enrollment

1,000 participants

Start Date

Dec 30, 2024

Study Type

OBSERVATIONAL

Conditions

Acute Ischemic Stroke Ischemic Stroke Intracranial Aneurysm Aneurysmal Subarachnoid Hemorrhage Intracranial Aneurysm, Wide Neck Aneurysm, Large Neck Aneurysm Lesion

Summary

The MAESTRO registry is a post-market, single-arm, non-interventional, multicenter registry

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying All Microvention Class III implantable device CE marked and All Microvention Mechanical Thrombectomy Class III device CE marked for people with acute ischemic stroke, aneurysmal subarachnoid hemorrhage, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAll Microvention Class III implantable device CE marked

Endovascular treatment of ruptured or unruptured intracranial aneurysms with commercially available MicroVention implant devices.

DEVICEAll Microvention Mechanical Thrombectomy Class III device CE marked

Endovascular treatment of acute ischemic stroke with commercially available MicroVention devices.

Locations(1)

Álvaro Cunqueiro Hospital - University Hospital Complex of Vigo, Department of Radiology

Vigo, Pontevedra, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06494436

Related Trials

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

NCT0597668530 locations

Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy

NCT070496922 locations

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

NCT07361302246 locations

STROKE 120 ACTION Trial

NCT071353101 location

Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy

NCT077135372 locations